Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kumi Matsuno
Observed names:
K Matsuno,
K. Matsuno,
Kumi MATSUNO
Institution:
Bayer (Japan)
Observed institutions:
The University of Texas MD Anderson Cancer Center,
The University of Texas at San Antonio Health Science Center,
University of Tokyo Hospital,
Bayer (Japan),
Japan Pharmaceutical Manufacturers Association,
Mebiopharm Co., Ltd. (Japan),
Takeda (Japan),
The University of Tokyo
show all 8
OpenAlex ID:
A5085257574
A phase I pharmacokinetic (PK) study of MBP-426, a novel liposome encapsulated oxaliplatin
2009
·
K. K. Sankhala
, A. C. Mita
, et al.
·
Journal of Clinical Oncology
·
84
Influence of glutathione S-transferase A1 polymorphism on the pharmacokinetics of busulfan
2006
·
Makiko Kusama
, Takahiro Kubota
, et al.
·
Clinica Chimica Acta
·
68
Genetic analysis of glutathione S-transferase A1 and T1 polymorphisms in a Japanese population
2004
·
Kumi Matsuno
, Takahiro Kubota
, et al.
·
Clinical Chemistry and Laboratory Medicine (CCLM)
·
25
Pharmacokinetics, Safety, and Tolerability of Vortioxetine Following Single‐ and Multiple‐Dose Administration in Healthy Japanese Adults
2017
·
Kumi Matsuno
, Koki Nakamura
, et al.
·
Clinical Pharmacology in Drug Development
·
16
PDF
Absorption, distribution, metabolism and excretion of molidustat in healthy participants
2020
·
Silvia Lentini
, Dorina van der Mey
, et al.
·
Basic & Clinical Pharmacology & Toxicology
·
15
PDF
Effects of oral iron and calcium supplement on the pharmacokinetics and pharmacodynamics of molidustat: an oral HIF–PH inhibitor for the treatment of renal anaemia
2020
·
Silvia Lentini
, Andreas Kaiser
, et al.
·
European Journal of Clinical Pharmacology
·
11
PDF
Pharmacokinetics, safety, and tolerability of the novel tetrameric gadolinium-based MRI contrast agent gadoquatrane in healthy Chinese and Japanese men: Two randomized dose-escalation studies including concentration–QTc modeling
2024
·
Xuemei He
, Shunji Matsuki
, et al.
·
European Journal of Pharmaceutical Sciences
·
10
Sp428a Randomized, Single-center, Double-blind, Placebo-controlled, Multiple-dose, Phase 1 Study to Evaluate the Safety, Pharmacokinetics (pk), and Pharmacodynamics (pd) of Tak-272 in Healthy Adult Non-elderly and Elderly Male Subjects
2017
·
K Matsuno
, S Tanaka
, et al.
·
Nephrology Dialysis Transplantation
·
9
PDF
A Multicenter, Phase III Evaluation of the Efficacy and Safety of a New Fixed-Dose Pioglitazone/Glimepiride Combination Tablet in Japanese Patients with Type 2 Diabetes
2013
·
Shinzo Hiroi
, Kenkichi Sugiura
, et al.
·
Diabetes Technology & Therapeutics
·
8
A new method for determination of buformin in plasma and urine by ion‐paired reversed‐phase HPLC with ultraviolet detection
2002
·
Takehito Yamamoto
, Makiko Kusama
, et al.
·
Biomedical Chromatography
·
6
Pharmacokinetics, Pharmacodynamics and Safety of a Single Dose of Imarikiren, a Novel Renin Inhibitor, in Healthy Male Subjects
2018
·
Kumi Matsuno
, Shingo Kuroda
, et al.
·
Basic & Clinical Pharmacology & Toxicology
·
4
PDF
A Randomized, Single‐Center, Double‐Blind, Placebo‐Controlled Multiple‐Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Imarikiren in Healthy Adult Nonelderly and Elderly Male Subjects
2018
·
Kumi Matsuno
, Shingo Tanaka
, et al.
·
The Journal of Clinical Pharmacology
·
3
PDF
Mo020safety, Tolerability, Pharmacokinetics (pk), and Pharmacodynamics (pd) of Single Doses of Tak-272, a Novel Renin Inhibitor, in Healthy Male Subjects
2017
·
K Matsuno
, S Kuroda
, et al.
·
Nephrology Dialysis Transplantation
·
3
PDF
Safety, Pharmacodynamics and Pharmacokinetics of the Oral Selective Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor Molidustat in Japanese Healthy Subjects
2018
·
Kenichi Yoshikawa
, Miho Uemura
, et al.
·
Proceedings for Annual Meeting of The Japanese Pharmacological Society
·
2
PDF
Bioequivalence of a pioglitazone–glimepiride combination tablet versus coadministered single-dose pioglitazone and glimepiride in healthy Japanese subjects
2012
·
Shinzo Hiroi
, Kumi Matsuno
, et al.
·
Diabetes Management
·
2
Bioequivalence evaluation of pioglitazone orally disintegrating tablet formulation
2012
·
Shinzo Hiroi
, Kumi Matsuno
, et al.
·
Diabetes Management
·
1
Evaluation of the bioequivalence of a fixed-dose combination tablet of pioglitazone–metformin versus commercial tablets in healthy Japanese male volunteers
2012
·
Shinzo Hiroi
, Kumi Matsuno
, et al.
·
Diabetes Management
·
1
Current Status and Future Prospects of Biomarker Strategy for Drug Development
2020
·
Takayo UENO
, Nobuko MATSUSHIMA
, et al.
·
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
PDF
Pharmacokinetics and Safety After a Single Dose of Imarikiren in Subjects with Renal or Hepatic Impairment
2018
·
Yukio Shimasaki
, Masashi Sakaki
, et al.
·
Clinical Drug Investigation
PDF
Show more works
View as search
Works count:
19
Citation count:
268
H-index:
8
I10-index:
7
Year
Topic
Type